Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
XIFAXAN ® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea ...
FDA Approves Lilly's Omvoh® (Mirikizumab-Mrkz) For Crohn's Disease, Expanding Its Use To The Second Major Type Of Inflammatory Bowel Disease
In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...
manilatimes5d
Regeneron Provides Business Updates and Highlights from Broad Clinical Pipeline at the 43rd Annual J.P. Morgan Healthcare Conference
EYLEA HD® and EYLEA® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on preliminary (unaudited) results EYLEA HD ...
Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch
NDAQ:AVDL) Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch ...
thehealthy16d
FDA Announcement: The First Generic GLP-1 Shot Has Just Been Approved
Many diabetes patients have experienced lowered drug costs in recent years, thanks to policies that have capped the price of diabetes prescriptions. For patients who have been paying for Ozempic or ...
Forbes16d
Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver
But a new report from GlobalData indicates Zepbound is poised to overtake other GLP-1 drugs. “Zepbound’s superior efficacy and strategic market expansion suggest that the drug will dominate ...
NDTV21d
People In USA Left Amazed When They're Calling 1-800-242-8478. Here's Why
(Representational) Something unusual happened when a journalist in New York called a toll-free 1-800 number last week. The reason for the call wasn't to reach a particular product helpline ...
Fox 921d
New MN law capping some prescription drug prices goes into effect Jan. 1
A new state law that caps the price of specific medications and medical supplies for chronic diseases goes into effect on Jan. 1. This new law could save some families thousands of dollars a year.
ABC News22d
Systane eye drops recalled due to fungal contamination: FDA
MORE: Be wary of unproven eye drop treatment with amniotic fluid, FDA says "Alcon is conducting a voluntary recall of one (1) lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go ...
healthday22d
FDA Approves Generic GLP-1 Medicine For Diabetes Treatment
The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living with Type 2 diabetes. Liraglutide, the ...
U.S. News & World Report22d
FDA Approves Generic GLP-1 Medicine For Diabetes Treatment
The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living with Type 2 diabetes. Liraglutide ...
ConsumerAffairs23d
FDA approves generic GLP-1 drug to treat type 2 diabetes
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), significantly improving access to diabetes treatment. The glucagon-like peptide-1 ...